YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Medical researcher in gloves using a tablet ©Adobe Stock Images Phio Pharmaceuticals has strengthened the intellectual property protection surrounding its INTASYL® gene silencing platform after receiving multiple favorable patent decisions…
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now availabl…
Virtual Investor Conferences NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, h…
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are no…
Virtual Investor Conferences Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary inve…
KING OF PRUSSIA, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to elim…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Quince Therapeutics Inc. 431,482,875 0.337 0.2459 0.2623 +0.1323 Phio Phar…
(RTTNews) - Phio Pharmaceuticals Corp. (PHIO), a clinical-stage siRNA biopharmaceutical, announced that it has taken a critical step forward by commencing a toxicology study, which the FDA requires before beginning a human pivotal trial in…
NEW YORK, NY / ACCESS Newswire / October 31, 2025 / We are pleased to announce Sidoti & Company, LLC, has recently expanded its equity research coverage in the healthcare industry to now include biotechnology, medical devices/diagnostics,…
(RTTNews) - Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor conference appearances. Companies like…
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT OCTO [https://www.ch…
Investing.com -- Phio Pharmaceuticals Corp (NASDAQ:PHIO) stock surged 26% after the company announced it has entered into a drug substance development services agreement with a U.S. manufacturer for its lead compound PH-762. The agreement…
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT HTOO [https://www.chartmill.com/stock/quote/HTOO/profile] 97.89% FUSION FUEL GREEN PLC-A'S…
* Phio Pharmaceuticals (NASDAQ:PHIO [https://seekingalpha.com/symbol/PHIO]) has entered [https://seekingalpha.com/pr/20178139-phio-pharmaceuticals-announces-agreement-with-u-s-manufacturing-source-for-drug-substance] into a comprehensive d…
Investing.com - H.C. Wainwright has reiterated its buy rating and $14.00 price target on Phio Pharma (NASDAQ:PHIO), representing significant upside from the current price of $2.17. According to InvestingPro data, the stock has shown strong…
MARLBOROUGH, MASSACHUSETTS - Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a $10.6 million market cap biotechnology company whose stock has gained over 22% year-to-date, announced Wednesday that its Safety Monitoring Committee has recommended…
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 28th: Phio Pharmaceuticals PHIO: This company which is focused on developing immuno-oncology therapeutics based on its proprietary se…
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, April 23: Casella Waste Systems, Inc. CWST: This integrated solid waste services company has a Zacks Rank #1 and witnessed the Zacks Con…
Here are two stocks with buy rank and strong value characteristics for investors to consider today, April 23: Phio Pharmaceuticals Corp. PHIO: This immuno-oncology biotech company carries a Zacks Rank #1, and has witnessed the Zacks Consen…
MARLBOROUGH, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in…
MARLBOROUGH, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in…
MARLBOROUGH, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in…
MARLBOROUGH, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in…
--Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination --Preclinical data demonstrates the effectiveness of PH-894 as an antitumor cytotoxic agent (dir…
MARLBOROUGH, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killi…
MARLBOROUGH, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in…
MARLBOROUGH, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in…
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA),…
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA),…
Good morning, trader! Let’s get this party started with a dive into the biggest pre-market stock movers for Wednesday! Wall Street in the early morning representing pre-market stock movers. Source: Eric Urquhart/Shutterstock.com We’ve got…
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS) gained 28.4% to $47.10. Dutch Bros shares surged around 60%…
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as the most-discussed stock on Reddit’s r/WallStreetBets forum as of Wednesday night. TMC the metals company Inc.…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 25) Cellect Biotechnology Ltd. (NASDAQ: APOP) ( announced a reverse merger) GenMark Diagnostics…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D Molecular Therapeutics Inc (NASDAQ: FDMT) Adagene Inc (NASDAQ: ADAG) (went public Tuesday…